At Home Care

Home Nursing, Elderly Care & Patient Care Services in Gurgaon | AtHomeCare
AtHomeCare Logo
ATHOMECARE™ KEEPING YOU WELL AT HOME
24×7 Medical Support
+91 99108 23218
Book Consultation

Why is AtHomeCare the Best Home Care in Gurgaon?

AtHomeCare India is the only truly integrated home healthcare provider in Gurgaon, offering all critical services under one roof—without outsourcing.

Home-Based CIDP Recovery: A Structured Rehabilitation Case Study from Gurgaon

CIDP Recovery at Home: Wheelchair to Walking in 6 Months
Case Study Published 2026

CIDP Rehabilitation at Home: From Wheelchair to Walking in Six Months

A 58-year-old business owner with Chronic Inflammatory Demyelinating Polyneuropathy was discharged after 16 days of hospital treatment, still wheelchair-dependent with significant weakness in all four limbs. This case study documents how six months of structured home rehabilitation restored his ability to walk and return to work.

58
Age (Years)
6
Months of Rehab
0
Readmissions
16
Hospital Days
Male
Golf Course Ext. Road, Gurgaon
CIDP
Business Owner
IVIG + Steroids
Returned to Walking

Patient Background

Mr. S.P. is a 58-year-old business owner living on Golf Course Extension Road, Gurgaon, Haryana. He is married, and his primary caregivers are his wife and son. Before his illness, he led an active professional life managing his business independently.

Past Medical History

Type 2 Diabetes Mellitus
Duration: 12 years
Hypertension
Duration: 10 years
Hyperlipidaemia
Duration not specified
No History Of
Stroke, cardiac surgery, or family neurological disorders

How the Illness Began

Symptoms developed gradually over approximately 5 months. Mr. S.P. first noticed numbness in both feet. He found it increasingly difficult to climb stairs and became fatigued after walking short distances. He started tripping frequently while walking and noticed reduced grip strength in his hands.

The family initially attributed these symptoms to his long-standing diabetes. Diabetic peripheral neuropathy is a common explanation for such symptoms, and this assumption is understandable. However, despite treatment for diabetes, the weakness continued to progress.

Neurological Progression Over Three Months

As the condition worsened, the clinical picture extended well beyond what would be expected from diabetic neuropathy alone:

Arm Weakness
Spread to both arms
Fine Motor Loss
Buttoning, writing
Balance Loss
Multiple falls
Severe Fatigue
Muscle exhaustion
Neuropathic Pain
Burning in both legs
Walker Dependent
Indoor mobility

Clinical Diagnosis

Chronic Inflammatory Demyelinating Polyneuropathy

Chronic

Commonly abbreviated as CIDP

CIDP is an acquired immune-mediated inflammatory disorder of the peripheral nervous system. The immune system mistakenly attacks the myelin sheath surrounding peripheral nerves, leading to progressive weakness and sensory loss. Unlike Guillain-Barre Syndrome, which is acute, CIDP develops over weeks to months and requires long-term immunomodulatory treatment. The diagnosis was confirmed through neurological evaluation, nerve conduction studies, and CSF analysis at a tertiary neurological centre in Gurgaon.

Investigations Performed

MRI Brain
MRI Spine
Nerve Conduction Velocity (NCV)
Electromyography (EMG)
Lumbar Puncture
CSF Analysis
Complete Blood Profile
Autoimmune Workup
ECG and Chest X-ray
Understanding CIDP: A Clinical Note

CIDP is important to distinguish from diabetic neuropathy because the treatment approaches are fundamentally different. Diabetic neuropathy is managed with glucose control and symptomatic treatment. CIDP requires immunomodulatory therapy such as intravenous immunoglobulin (IVIG) or corticosteroids. The key diagnostic clues in Mr. S.P.’s case were the rapid progression of weakness, involvement of all four limbs, and the presence of demyelinating features on nerve conduction studies. The CSF analysis showing elevated protein with normal cell count (albuminocytologic dissociation) further supported the diagnosis.

Hospital Treatment (16 Days)

Treatment Received

1
Intravenous Immunoglobulin (IVIG)

The primary immunomodulatory treatment for CIDP. IVIG provides antibodies that modulate the abnormal immune response attacking the peripheral nerves.

2
Corticosteroid Therapy

To suppress the inflammatory immune response. Given Mr. S.P.’s 12-year history of diabetes, steroid use required careful blood glucose monitoring, as corticosteroids significantly raise blood sugar levels.

3
Intensive Physiotherapy

Initial mobility assessment and strengthening exercises were started during the hospital stay to prevent muscle wasting and joint stiffness.

4
Occupational Therapy and Pain Management

To address fine motor difficulties and neuropathic pain. Regular neurology consultations monitored treatment response.

Condition at Discharge

Wheelchair for outdoor mobility
Walker for indoor movement
Moderate weakness in all four limbs
Unable to climb stairs
Assistance needed for bathing and dressing
Significant fatigue after minimal activity
High risk of falls
Discharge Recommendation

The neurologist recommended structured home rehabilitation for at least six months. The medical treatment had stabilised the immune attack, but significant functional recovery required sustained, intensive physiotherapy that could be best delivered in the home setting.

Why Home Healthcare Was Recommended

Rehabilitation requires daily, intensive physiotherapy

CIDP rehabilitation is not a weekly session. The neurologist recommended 6 physiotherapy sessions per week. Travelling to a clinic 6 times per week while wheelchair-dependent would be exhausting for the patient and logistically difficult for the family. Home physiotherapy allowed the patient to receive intensive treatment without the physical toll of repeated travel.

Blood sugar monitoring during steroid treatment

Corticosteroids cause significant blood sugar elevation. In a patient with 12 years of Type 2 Diabetes, this required careful daily monitoring. Skilled home nursing provided this monitoring alongside medication supervision, ensuring that diabetes control was not lost during CIDP treatment.

Fall risk was significant and ongoing

With weakness in all four limbs, balance problems, and a history of multiple falls, Mr. S.P. needed a safe environment with supervision during all mobility attempts. A trained patient attendant provided this safety net during the high-risk early rehabilitation period.

CIDP rehabilitation is a long-term process

The neurologist recommended at least six months of rehabilitation. This is not a condition that resolves in days. A home-based patient care services programme provides the continuity needed for long-term recovery, with consistent therapists and nurses who track progress over months.

Psychological impact of sudden disability

A 58-year-old active business owner becoming wheelchair-dependent within months has significant psychological impact. Recovery in a familiar home environment, surrounded by family, with the goal of returning to work, provided motivation that a hospital or rehabilitation facility could not replicate.

Home Care Plan by AtHomeCare

The care plan was designed around two parallel priorities: medical safety during the steroid and IVIG phase, and intensive rehabilitation to restore functional independence.

Physiotherapy: 6 Sessions Per Week

This was the cornerstone of the rehabilitation plan. The intensity of 6 sessions per week reflected the neurologist’s assessment that aggressive rehabilitation was needed to maximise recovery during the period when nerve remyelination was active.

Progressive strengthening exercises
Balance and coordination training
Gait training with walker, then cane
Range of motion exercises
Safe transfer techniques
Progressive resistance as strength improved

Skilled Home Nursing

The nursing role was critical in this case because of the intersection of CIDP treatment with pre-existing diabetes and hypertension. Corticosteroids required daily blood glucose monitoring and potential insulin adjustment. Blood pressure needed regular checks. Medication compliance for multiple conditions had to be supervised.

Blood glucose monitoring (daily, due to steroids)
Blood pressure monitoring
Medication administration and supervision
Monitoring for steroid side effects

Patient Attendant (12-Hour Shift)

A trained attendant was placed for 12 hours daily to assist with mobility, transfers, personal care, and to provide fall supervision during the high-risk early rehabilitation period. As the patient’s strength improved, the attendant’s role shifted from physical support to safety monitoring.

Occupational Therapy Guidance

Mr. S.P. had difficulty with fine motor tasks such as buttoning clothes and writing. Occupational therapy guidance was integrated into the home programme to help him regain hand function, which was essential for his goal of returning to office work.

Home Safety, Nutrition, and Family Education

Home safety assessment was conducted to reduce fall hazards. Nutritional planning supported muscle recovery. Family education ensured the wife and son understood the rehabilitation plan, could assist safely, and recognised warning signs that required medical attention.

Rehabilitation Milestones

Unlike the PSP case study, where the goal was stabilisation, this case involved genuine functional recovery. The milestones below document measurable improvements in Mr. S.P.’s abilities over the six-month home rehabilitation period.

At Discharge High Fall Risk
  • Wheelchair for outdoor mobility
  • Walker for indoor movement
  • Required assistance with bathing and dressing
  • Significant fatigue after minimal activity
Week 2 Early Progress
  • Improved sitting balance
  • Better grip strength
  • Reduced burning pain
  • Independent feeding achieved
Week 6 Meaningful Gains
  • Walking indoors with walker
  • Improved hand coordination
  • Able to perform basic grooming independently
Month 3 Strong Progress
  • Walking 40 to 50 metres with supervision
  • Improved lower-limb strength
  • Fewer fatigue episodes
  • Better confidence in mobility
Month 6 Significant Recovery
  • Independent indoor walking
  • Outdoor walking with a cane
  • Returned to office work for a few hours each day
  • No hospital readmissions during the entire period
  • Significant improvement in overall independence

Clinical Evidence

Transparency note: Specific laboratory values, exact blood pressure and blood glucose readings, and precise NCV/EMG parameters from the home care period were not included in the documentation available for this case study. The tables below reflect clinically documented observations and outcomes.

Functional Status: Discharge vs Month 6

ParameterAt DischargeAt Month 6Change
Outdoor MobilityWheelchairWalking with caneMajor improvement
Indoor MobilityWalkerIndependent walkingMajor improvement
Grip StrengthReducedImprovedImproved
Fine Motor (buttoning, writing)DifficultImprovedImproved
Bathing and DressingRequired assistanceIndependentImproved
FeedingNot documented as dependentIndependentMaintained
Fatigue LevelSignificant after minimal activityFewer episodesImproved
Fall IncidentsMultiple (pre-admission)No falls during rehabPrevented
Hospital ReadmissionsLeading to admissionZeroPrevented
Work StatusUnable to workOffice work, few hours dailySignificant

Challenges Managed During Home Care

ChallengeIntervention
Progressive limb weakness6x/week physiotherapy with progressive strengthening
Neuropathic pain (burning in legs)Medication management, reduced over time
Poor balance and fall riskGait training, attendant supervision, home safety modifications
Blood sugar elevation from steroidsDaily glucose monitoring by nurse, medication adjustment
Muscle wastingProgressive resistance exercises, nutritional support
Fear of fallingGraduated mobility programme, confidence-building approach
Emotional distressFamily support, goal-oriented rehabilitation, return-to-work planning

Medical Authority

Dr. Ekta Fageriya
Dr. Ekta Fageriya
MBBS
RMC Registration 44780
Specialisation Geriatric Medicine
Clinical Experience 7 Years

Supporting Clinical Documents

This case study is based on the following clinical documentation. Patient identifiers have been removed to protect confidentiality.

Hospital Discharge Summary
16-day admission record
Neurology Consultation Notes
CIDP diagnosis confirmation
NCV and EMG Reports
Demyelinating features documented
CSF Analysis Report
Albuminocytologic dissociation
Physiotherapy Progress Records
6-month rehabilitation documentation
Home Care Nursing Records
Vital signs, medication, glucose logs

Confidentiality: All patient identifiers, exact dates, specific medication names and dosages, and precise investigation values have been withheld or generalised in accordance with patient confidentiality requirements.

Clinical Outcome

CIDP remains a chronic neurological condition requiring ongoing neurological follow-up. The improvement achieved does not represent a cure. However, the functional recovery was substantial and directly attributable to the combination of appropriate medical treatment (IVIG and corticosteroids) and intensive, sustained home rehabilitation.

Mobility

  • From wheelchair to cane-assisted walking
  • Independent indoor walking
  • Walking 40-50 metres with supervision by month 3

Safety

  • Zero hospital readmissions in 6 months
  • No falls during rehabilitation period
  • Reduced fall risk through progressive training

Medical Management

  • Better diabetes control despite steroid use
  • Improved medication adherence
  • Steroid side effects monitored and managed

Quality of Life

  • Returned to office work (few hours daily)
  • Increased independence in daily activities
  • Reduced caregiver burden

Key Clinical Learnings

1

CIDP is treatable, but only if correctly diagnosed

The initial assumption that Mr. S.P.’s symptoms were due to diabetic neuropathy delayed the correct diagnosis. CIDP requires specific immunomodulatory treatment that is completely different from the management of diabetic neuropathy. This case reinforces the importance of neurological referral when peripheral neuropathy symptoms progress rapidly or involve more than just the distal sensory distribution typical of diabetes.

2

Rehabilitation intensity matters

The neurologist specifically recommended 6 physiotherapy sessions per week, not 2 or 3. This level of intensity would be nearly impossible to sustain through hospital or clinic visits for a wheelchair-dependent patient. Home-based delivery made this intensity achievable, and the outcomes suggest it was a key factor in the degree of recovery achieved.

3

Steroid use in diabetic patients requires dedicated nursing oversight

Corticosteroids are essential for CIDP treatment but cause significant blood sugar elevation. Without daily glucose monitoring and medication adjustment by a skilled nurse, Mr. S.P.’s diabetes could have deteriorated significantly during treatment. This intersection of conditions is where home nursing adds the most value.

4

Goal-oriented rehabilitation improves motivation

Mr. S.P.’s goal of returning to his business provided clear motivation. The rehabilitation team structured milestones around this goal, progressing from basic feeding to indoor walking to returning to office. Having a tangible, personally meaningful endpoint made the difficult months of rehabilitation more tolerable.

5

Fall prevention during rehabilitation is as important as the exercises themselves

A patient who is actively trying to walk again after being wheelchair-dependent is at high risk of falls. The presence of a trained attendant during the early months, combined with a home environment modified for safety, meant that attempts at increased mobility did not result in injuries that could have set back the rehabilitation by weeks.

Frequently Asked Questions

CIDP is an autoimmune disorder in which the body’s immune system attacks the myelin sheath that surrounds peripheral nerves. Myelin acts like insulation on electrical wires, and when it is damaged, nerve signals become slow or blocked. This causes progressive weakness, numbness, and loss of balance. Unlike Guillain-Barre Syndrome, which develops over days, CIDP develops over weeks to months and requires long-term treatment.

Diabetic neuropathy typically causes sensory symptoms (numbness, tingling) that start in the feet and progress slowly over years. CIDP causes both sensory and motor symptoms (weakness), progresses over weeks to months, and affects all four limbs. Most importantly, diabetic neuropathy is managed with glucose control, while CIDP requires immunomodulatory treatment such as IVIG or corticosteroids. When a diabetic patient develops rapidly progressive weakness, CIDP should be considered.

Intravenous Immunoglobulin (IVIG) is a preparation of antibodies collected from healthy donors. In CIDP, it works by modulating the abnormal immune response, essentially distracting the immune system from attacking the peripheral nerves. IVIG is one of the first-line treatments for CIDP and has strong evidence supporting its effectiveness. It is administered intravenously over several hours, typically in cycles repeated every few weeks.

Recovery varies significantly between individuals. Many CIDP patients achieve substantial functional improvement with appropriate treatment and rehabilitation, as seen in this case. However, CIDP is a chronic condition and some degree of residual symptoms may persist. Ongoing neurological follow-up is essential because relapses can occur. The goal of treatment is to maximise function and prevent relapse, not necessarily to achieve a complete return to pre-illness status.

CIDP causes demyelination of peripheral nerves, and recovery depends on remyelination and neural adaptation. Research in neurological rehabilitation suggests that high-frequency, intensive therapy early in the recovery phase produces better outcomes than low-frequency therapy. The neurologist’s recommendation of 6 sessions per week reflected the urgency of capitalising on the post-treatment window when nerve recovery was most active. Delivering this intensity at home was far more practical than hospital or clinic visits.

In CIDP, physiotherapy focuses on strengthening muscles that have weakened due to impaired nerve signals, retraining balance and coordination, and progressively challenging gait to restore walking ability. It also prevents secondary complications such as joint contractures and muscle wasting that occur when limbs are not used. The programme must be graduated, starting with basic exercises and progressively increasing difficulty as nerve function improves.

The critical nursing role in this case was blood glucose monitoring. Mr. S.P. had 12 years of diabetes and was started on corticosteroids, which significantly raise blood sugar. Without daily monitoring and potential medication adjustment, his diabetes could have spiralled out of control. The nurse also supervised medication for multiple conditions (CIDP, diabetes, hypertension, hyperlipidaemia), monitored for steroid side effects, and coordinated with the treating neurologist. This level of daily medical oversight is exactly what skilled home nursing provides.

NCV studies measure the speed and strength of electrical signals travelling along peripheral nerves. In CIDP, demyelination causes显著 slowing of nerve conduction velocity, and there may be conduction block. These findings, particularly when they affect multiple nerves, are a key diagnostic criterion for CIDP. NCV helps distinguish CIDP from axonal neuropathies (like advanced diabetic neuropathy) where the primary problem is nerve fibre loss rather than myelin damage.

Yes. CIDP is a chronic condition and relapses can occur, even after significant recovery. This is why ongoing neurological follow-up is essential. Patients may need maintenance IVIG or steroid therapy, and the treatment plan may need to be adjusted over time. Having an established home healthcare team that knows the patient’s baseline makes it easier to detect early signs of relapse and respond quickly, potentially through escalated care at home if needed.

A neurological evaluation should be sought when weakness progresses rapidly over weeks to months, when weakness affects both arms and legs (not just the feet), when balance problems lead to falls, when fine motor tasks become difficult, or when symptoms are more severe than would be expected from the patient’s known conditions (such as diabetes duration and control level). Early referral allows earlier diagnosis and treatment, which in conditions like CIDP directly affects the degree of recovery possible.

Need Home Healthcare Support in Gurgaon?

If you or a family member is recovering from a neurological condition, our clinical team can develop a structured rehabilitation plan for home.

Corporate Office
Unit No. 703, 7th Floor, ILD Trade Centre
D1 Block, Malibu Town
Sector 47, Gurgaon, Haryana 122018
Call 9910823218

Medical Disclaimer

Every patient is unique. The outcomes described in this case study relate to a specific patient and cannot be generalised to other individuals with CIDP or any other medical condition.

Treatment decisions must always be made by qualified healthcare professionals based on a thorough evaluation of the individual patient’s medical history, current condition, and specific needs.

If you or a family member experiences sudden weakness, difficulty breathing, loss of sensation, or inability to walk, seek immediate medical attention. Home healthcare complements, but does not replace, emergency medical services.

This case study is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or a treatment recommendation for any reader.

Leave A Comment

All fields marked with an asterisk (*) are required